OrganoClick AB Statistics
Total Valuation
OrganoClick AB has a market cap or net worth of SEK 58.96 million. The enterprise value is 138.08 million.
| Market Cap | 58.96M |
| Enterprise Value | 138.08M |
Important Dates
The next confirmed earnings date is Friday, July 17, 2026.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OrganoClick AB has 110.00 million shares outstanding. The number of shares has increased by 6.91% in one year.
| Current Share Class | 110.00M |
| Shares Outstanding | 110.00M |
| Shares Change (YoY) | +6.91% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.36% |
| Owned by Institutions (%) | 14.49% |
| Float | 46.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.60 |
| PB Ratio | 3.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 125.18 |
| P/OCF Ratio | 33.22 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.00 |
| EV / Sales | 1.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 293.16 |
Financial Position
The company has a current ratio of 0.50, with a Debt / Equity ratio of 4.13.
| Current Ratio | 0.50 |
| Quick Ratio | 0.21 |
| Debt / Equity | 4.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | 164.40 |
| Interest Coverage | -3.32 |
Financial Efficiency
Return on equity (ROE) is -136.50% and return on invested capital (ROIC) is -13.80%.
| Return on Equity (ROE) | -136.50% |
| Return on Assets (ROA) | -8.75% |
| Return on Invested Capital (ROIC) | -13.80% |
| Return on Capital Employed (ROCE) | -55.65% |
| Weighted Average Cost of Capital (WACC) | 7.78% |
| Revenue Per Employee | 2.52M |
| Profits Per Employee | -885,154 |
| Employee Count | 39 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 2.42 |
Taxes
In the past 12 months, OrganoClick AB has paid 103,000 in taxes.
| Income Tax | 103,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.01% in the last 52 weeks. The beta is 0.83, so OrganoClick AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -73.01% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 1.52 |
| Relative Strength Index (RSI) | 39.83 |
| Average Volume (20 Days) | 94,696 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OrganoClick AB had revenue of SEK 98.16 million and -34.52 million in losses. Loss per share was -0.33.
| Revenue | 98.16M |
| Gross Profit | 20.16M |
| Operating Income | -22.72M |
| Pretax Income | -35.99M |
| Net Income | -34.52M |
| EBITDA | -19.38M |
| EBIT | -22.72M |
| Loss Per Share | -0.33 |
Balance Sheet
The company has 3.05 million in cash and 77.43 million in debt, with a net cash position of -74.38 million or -0.68 per share.
| Cash & Cash Equivalents | 3.05M |
| Total Debt | 77.43M |
| Net Cash | -74.38M |
| Net Cash Per Share | -0.68 |
| Equity (Book Value) | 18.77M |
| Book Value Per Share | 0.13 |
| Working Capital | -52.98M |
Cash Flow
In the last 12 months, operating cash flow was 1.78 million and capital expenditures -1.30 million, giving a free cash flow of 471,000.
| Operating Cash Flow | 1.78M |
| Capital Expenditures | -1.30M |
| Depreciation & Amortization | 3.34M |
| Net Borrowing | -9.05M |
| Free Cash Flow | 471,000 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 20.54%, with operating and profit margins of -23.14% and -35.17%.
| Gross Margin | 20.54% |
| Operating Margin | -23.14% |
| Pretax Margin | -36.66% |
| Profit Margin | -35.17% |
| EBITDA Margin | -19.74% |
| EBIT Margin | -23.14% |
| FCF Margin | 0.48% |
Dividends & Yields
OrganoClick AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.91% |
| Shareholder Yield | -6.91% |
| Earnings Yield | -58.55% |
| FCF Yield | 0.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |